Your browser doesn't support javascript.
loading
Solitary serum methotrexate level 36 hours post high-dose methotrexate: A safe, efficacious, and cost-effective strategy to monitor methotrexate toxicities in childhood leukemia in resource-limited centers.
Khera, Sanjeev; Kapoor, Rajan; Pramanik, Suman Kumar.
Afiliação
  • Khera S; Department of Pediatrics, Army Hospital Research and Referral, Delhi, 110010, India.
  • Kapoor R; Department of Hematology, Command Hospital Kolkata, Kolkata, West Bengal, India.
  • Pramanik SK; Department of Hematology, Army Hospital Research and Referral, Delhi, India.
Pediatr Blood Cancer ; 67(7): e28387, 2020 07.
Article em En | MEDLINE | ID: mdl-32400952
ABSTRACT

BACKGROUND:

The standard practice during high-dose methotrexate (HD-MTX) in acute lymphoblastic leukemia (ALL) to mitigate toxicity is to serially monitor levels till serum MTX < 0.01 µmol/L. Most resource-limited centers lack in-house access to MTX levels, and therefore repeated monitoring is costly and cumbersome. We studied the efficacy and safety of "solitary 36 hours post HD-MTX levels (MTX36 )." PROCEDURE This prospective observational study consecutively enrolled children with ALL receiving HD-MTX. Cycles with unavailable MTX36 and MTX36  > 10 µmol/L were excluded. HD-MTX was administered over 24 hours (BFM-2009 protocol) with 12 hours of prehydration. MTX36 were performed at other centers. Leucovorin was given in six hourly doses 36 hours post HD-MTX. Hydration was continued until the last dose of leucovorin. MTX toxicities, including change of creatinine from baseline at 36 hours (∆Cr36 ), were noted. Two groups depending on MTX36 (≤1 µmol/L vs > 1 µmol/L) received six versus eight doses of leucovorin, and toxicities were compared.

RESULTS:

Twenty-nine children with median age five years (1-11) who received 100 HD-MTX cycles with a median MTX dose of 3 g/m2 (2-5) were analyzed. The median MTX36 level was 1.165 µmol/L (0.1-7.32). Toxicities of HD-MTX (CTCAE-4.0) transaminitis-22%; creatinine elevation ≥ 1.25 times baseline-24%; cytopenias-16%; mucositis-17%; acute kidney injury (AKI)-6%. All toxicities were ≤CTCAE grade 3. Creatinine elevation, AKI, and mucositis were significantly higher in the group with higher MTX36 . There was no correlation (r = 0.3) between ∆Cr36 and MTX36 . MTX36 was thrice more economical than the standard protocol.

CONCLUSION:

MTX36 is a potential cost-effective, efficacious, and safe limited sample strategy to monitor HD-MTX, particularly in centers where in-house MTX levels are unavailable.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metotrexato / Análise Custo-Benefício / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antimetabólitos Antineoplásicos Tipo de estudo: Etiology_studies / Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metotrexato / Análise Custo-Benefício / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antimetabólitos Antineoplásicos Tipo de estudo: Etiology_studies / Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article